Final results from a national multicenter phase II trial of combination bacillus Calmette-Guérin plus interferon α-2B for reducing recurrence of superficial bladder cancer☆-Reference-Cited by-同舟云学术

Final results from a national multicenter phase II trial of combination bacillus Calmette-Guérin plus interferon α-2B for reducing recurrence of superficial bladder cancer☆

Published:2006-07 Issue:4 Volume:24 Page:344-348
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Joudi Fadi N.,Smith Brian J.,O’Donnell Michael A.

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference9 articles.

1. Cancer statistics, 2004;Jemal;CA Cancer J Clin,2004

2. Management of superficial bladder cancer;Malkowicz,2002

3. Interferons and bladder cancer;Brown;Urol Clin North Am,2000

4. IFN-alpha 2B enhances Th1 cytokine responses in bladder cancer patients receiving Mycobacterium bovis bacillus Calmette-Guerin immunotherapy;Luo;J Immunol,1999

5. Management of bacillus Calmette-Guerin (BCG) refractory superficial bladder cancer;Punnen;Can J Urol,2003

Cited by 214 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)—A Summary of the 2024 Guidelines Update;European Urology;2024-08

2. A Multinational, Multi-Institutional Study Assessing the Impact of Diabetes Mellitus on the Prognosis of Patients with Non-Muscle Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin;Nutrition and Cancer;2024-07-07

3. Developments in conservative treatment for BCG-unresponsive non-muscle invasive bladder cancer;Expert Opinion on Pharmacotherapy;2024-07-02

4. An evaluation of nadofaragene firadenovec-vncg for the treatment of high-risk BCG-unresponsive non-muscle-invasive bladder cancer;Expert Opinion on Biological Therapy;2024-06-02

5. Documento multidisciplinar de consenso sobre el tratamiento actual del tumor vesical no-músculo invasor que no responde al tratamiento con bacilo Calmette-Guérin;Actas Urológicas Españolas;2024-05